Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Halozyme Therapeutics, Inc.

NASDAQ: HALO · Life Sciences · 10 alerts · CIK 1159036

Share price
$96.50Close, Nov 16
Market cap
$11B
Shares outstanding
114.01MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Halozyme Therapeutics, Inc. filings on SEC EDGAR ↗

4:20 PM ET 8-K
Leadership Change

Halozyme Therapeutics Leadership Change

Halozyme Therapeutics appointed James Daly to its Board of Directors, effective September 28, 2026. Mr. Daly will serve in the class of directors with a term ending at the 2029 annual meeting and will receive standard compensation under the company's non-employee director program.

Counterparty
James Daly

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.